Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections

NCT00990392 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-05-29

No results posted yet for this study

Summary

The purpose of the study is to determine if the overall central venous catheter related infection rate can be reduced by the application of Polysporin Triple Therapy ointment to the insertion site.

Conditions

  • Blood Stream Infections
  • Skin Diseases, Infectious

Interventions

DRUG

Polysporin Triple Therapy ointment

Polysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week.

OTHER

Petroleum Jelly

Petroleum jelly applied to the insertion point at the time of CVC placement and twice within the first week.

Sponsors & Collaborators

  • Fraser Health

    lead OTHER

Principal Investigators

  • Steven Reynolds, MD · Fraser Health Authority

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00990392 on ClinicalTrials.gov